Design strategy of antidote sequence for bivalent aptamer: Rapid neutralization of high‐anticoagulant thrombin‐binding bivalent DNA aptamer‐linked M08 with HD22
Abstract Background Bivalent thrombin‐binding aptamers (TBAs) have great potential for the treatment of thrombosis because they exhibit high anticoagulant activity, and their complementary single‐stranded DNA (ssDNA) sequences work as an antidote. However, a design strategy for antidote sequences ag...
Main Authors: | Toru Yoshitomi, Koji Wakui, Masato Miyakawa, Keitaro Yoshimoto |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-07-01
|
Series: | Research and Practice in Thrombosis and Haemostasis |
Subjects: | |
Online Access: | https://doi.org/10.1002/rth2.12503 |
Similar Items
-
Construction of a Bivalent Thrombin Binding Aptamer and Its Antidote with Improved Properties
by: Quintin W. Hughes, et al.
Published: (2017-10-01) -
Development of RNA Aptamers and Antidotes as Antithrombotic Therapeutics
by: Bompiani, Kristin
Published: (2012) -
Rapid Complexation of Aptamers by Their Specific Antidotes
by: Heidi Stoll, et al.
Published: (2017-06-01) -
Thermodynamic, Anticoagulant, and Antiproliferative Properties of Thrombin Binding Aptamer Containing Novel UNA Derivative
by: Weronika Kotkowiak, et al.
Published: (2018-03-01) -
Supramolecular Aptamers on Graphene Oxide for Efficient Inhibition of Thrombin Activity
by: Ting-Xuan Lin, et al.
Published: (2019-05-01)